 Kura Oncology NASDAQ:KURA was upgraded by Zacks Investment Research from a hold rating to a buy rating in a report released on Tuesday, Zacks.com reports. The firm currently has a 12.00 price target on the stock. Zacks Investment Researchs price target suggests a potential upside of 15.16 from the stocks current price. According to Zacks, ... 